Debating pros and cons of gene drives to control disease-carrying insects and other pests

Mosquitos may have killed more people than any other single cause. Credit: Ariel Davis
Mosquitos may have killed more people than any other single cause. Credit: Ariel Davis

British biotech company Oxitec plans to kick off a months-long experiment in which it will release billions of Aedes aegypti mosquitoes in California and Florida. But these aren’t just any mosquitoes — they’re genetically engineered so that they don’t bite, and will, if all goes according to plan, eventually reduce the population of mosquitoes in these areas.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

Proponents say, at scale, such a program would result in:

  • Less mosquito-borne illness
  • Little ecological impact since mosquitoes are not a keystone species
  • Less pesticide use, currently used against mosquitoes, which means better protection of local plants and animals
  • Little or no negative impact on humans as the mosquitoes are safe, quick, and effective

Opponents say:

  • Mosquitoes may not be a keystone species, but other animals do eat them and so eliminating the insects may in fact have an ecological impact
  • There could be unintended consequences, such as a hybrid species or the creation of a new ecological niche that other animals, which carry potentially even more lethal diseases, could move into
  • It takes expensive, large-scale trials to have certainty about safety and efficacy
Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

Others envision even more far-reaching applications, such as species conservation (by helping native species become immune to disease or even to the harsher conditions of climate change).

This is an excerpt. Read the original post here

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Picture1
Hiroshima at 81: America’s new nuclear bomb, a buried Iranian target, and a question no one wants to ask
png livestock cow cattle a
Consumer skepticism about gene-edited milk is neither fixed nor particularly high—and falls even more if it’s priced lower
ChatGPT-Image-Jul-31-2026-07_35_35-AM
Wikipedia has assembled an informative list of fake news websites from across the ideological spectrum
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-08-03-at-2.15.16-PM
Viewpoint: Trump’s relaxed controls on supplying China with microchips could undermine U.S. AI dominance
Screenshot-2026-08-03-at-2.25.49-PM
As measles vaccination rates collapse, scientists push for treatments long considered unnecessary
Screenshot-2026-07-31-at-10.52.03-AM
Love sweets and fatty foods? You can blame your genes, but there are ways to quell the obsessions
ChatGPT Image Jul 29, 2026, 09_08_15 AM 2
The retreat of environmental extremism: Why activist NGOs are losing favor
Screenshot-2026-07-17-at-1.34.59-PM
Poll: Vaccine hesitancy soars when patients distrust health providers and turn to social media
ChatGPT Image Jul 29, 2026, 10_17_59 AM
Viewpoint: What does it mean when critics of conventional agriculture say many fruits and vegetables are “linked” to pesticide poisoning?
Screenshot-2026-08-03-at-2.06.39-PM
Viewpoint: Green energy supporters ‘fight back’ against conservative foundations backing  fossil fuel industry
ChatGPT Image Jul 31, 2026, 08_05_37 AM
With trust in RFK, Jr.'s CDC vaccine advice collapsing, physicians scramble to fill the information gap
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.